Clinical Trial Update: Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 Mercury II trial compares the efficacy and safety of atorvastatin, simvastatin, and rosuvastatin in high-risk subjects with Type IIa/IIb hypercholestero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)
• Zocor (simvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED